BIA
ASND icon

Biondo Investment Advisors’s Ascendis Pharma A/S ASND Stock Holding History

Biondo Investment Advisors’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Sell
3,825
-250
-6% -$58.4K 0.12% 74
2026
Q1 		$932K Buy
4,075
+3,075
+308% +$689K 0.12% 68
2025
Q4 		$213K Buy
+1,000
New +$207K 0.03% 86

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Biondo Investment Advisors's ASND Position: Q2 2026 in Review

Biondo Investment Advisors reduced its Ascendis Pharma A/S (ASND) stake by 6.1% in Q2 2026, selling an estimated $58.4K and leaving 3,825 shares worth $1.02M. The position accounts for 0.12% of the portfolio, ranked #74.

Biondo Investment Advisors first reported a position in ASND in Q4 2025 and has held it in 3 quarters since. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Biondo Investment Advisors held 3,825 shares of Ascendis Pharma A/S worth $1.02M as of Q2 2026.
  • Biondo Investment Advisors sold 250 Ascendis Pharma A/S shares in Q2 2026, an estimated $58.4K.
  • Ascendis Pharma A/S made up 0.12% of Biondo Investment Advisors's portfolio in Q2 2026, its #74 holding.
  • Biondo Investment Advisors first reported a position in Ascendis Pharma A/S in Q4 2025 and has held it in 3 quarters since.
  • 313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Biondo Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.